Project - Industrial Scale Recombinant Lysozyme Production - ReLy: Sustainable and scalable production of recombinant lysozyme to replace traditional egg-based methods.

Project Start and End Dates
January 2025 - December 2027

Summary
ReLy is an innovative project aiming to revolutionize the production of lysozyme, a widely used antimicrobial enzyme in food, feed, and biotech industries. The project focuses on developing and scaling sustainable, recombinant lysozyme production using microbial cell factories as an alternative to traditional egg-based methods. By reducing greenhouse gas emissions, water usage, and waste, ReLy will contribute to a greener, more cost-efficient future. This solution will also address market demand fluctuations, improve supply chain stability, and open new applications for lysozyme in global markets.

Project Objectives

• Achieve robust microbial production of recombinant lysozyme.
• Identify cost-efficient and sustainable growth media for production.
• Scale production processes to pilot levels.
• Reduce greenhouse gas emissions and water consumption compared to traditional egg-based methods.
• Ensure the quality and functionality of recombinant lysozyme matches or exceeds current standards.
• Replace hen egg-based lysozyme production, improving animal welfare.
• Expand lysozyme applications, including new food and feed uses.

Participants

• Ovodan Biotech A/S
• Ovodan Foods A/S
• Technical University of Denmark (DTU)
• Danish Technological Institute (DTI)
• Process Engineering A/S